Chargement en cours...
Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa
Ceftolozane-tazobactam (C/T) is a novel beta-lactam–beta-lactamase inhibitor combination antibiotic approved by the U.S. Food and Drug Administration in 2014 for the treatment of complicated intra-abdominal infections (in combination with metronidazole) and complicated urinary tract infections. In t...
Enregistré dans:
| Publié dans: | J Clin Microbiol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6113460/ https://ncbi.nlm.nih.gov/pubmed/29976590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00717-18 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|